Vanda pharmaceuticals inc. (VNDA)
Income statement / Quarterly
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14Dec'13Sep'13Jun'13Mar'13Dec'12Sep'12Jun'12Mar'12Dec'11Sep'11Jun'11Mar'11Sep'10Jun'10
Revenues:
Net product sales

58,000

60,930

59,485

59,060

47,713

53,041

49,135

47,350

43,592

44,276

41,336

42,056

37,415

38,244

38,482

36,029

33,262

31,849

28,344

27,582

22,150

-

5,329

1,559

-

-

0

0

-

-

-

-

-

-

-

-

-

-

1,542

Royalty revenue

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

1,583

1,689

1,539

1,691

2,031

1,956

1,641

1,462

1,168

1,535

1,700

1,535

1,618

1,216

752

895

493

70

Licensing agreement

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

7,766

7,764

7,764

7,452

6,752

6,753

6,678

6,606

6,752

6,753

6,678

6,606

6,752

6,753

6,678

6,606

6,753

6,678

Total revenues

58,000

60,930

59,485

59,060

47,713

53,041

49,135

47,350

43,592

44,276

41,336

42,056

37,415

38,244

38,482

36,029

33,262

31,849

28,344

27,582

22,150

15,370

14,782

10,862

9,143

8,783

8,709

8,319

8,068

7,920

8,288

8,378

8,141

8,370

7,969

7,430

7,501

7,246

8,290

Operating expenses:
Cost of goods sold excluding amortization

5,207

-

-

-

5,113

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Cost of goods sold excluding amortization

-

-

6,782

6,368

-

5,667

5,068

5,213

4,560

4,791

4,525

4,529

4,003

5,272

6,990

6,494

5,956

6,171

6,510

5,766

5,015

-

703

198

-

-

-

-

-

-

-

-

-

-

-

-

-

-

1,516

Research and development

15,527

13,074

11,347

10,950

13,278

12,922

11,390

9,866

9,416

10,154

10,178

7,648

10,567

7,614

7,294

6,700

7,548

8,747

9,974

5,946

4,478

4,752

3,701

3,514

7,263

6,269

8,022

6,100

8,111

10,935

10,159

12,490

12,180

10,556

8,174

5,999

4,267

4,072

2,403

Selling, general and administrative

37,021

37,018

30,221

31,468

31,029

24,922

26,047

27,960

26,822

31,049

31,124

31,371

30,297

23,907

21,908

24,682

29,290

28,881

18,458

18,386

18,806

17,322

11,290

28,139

27,893

9,928

5,741

5,260

4,153

3,860

3,147

3,601

3,909

3,345

2,711

2,572

2,858

2,054

2,842

Intangible asset amortization

400

325

400

400

380

332

397

398

400

432

432

432

454

2,105

2,943

2,942

2,943

2,943

2,943

2,942

4,144

536

536

617

565

377

377

372

369

377

377

372

369

377

377

372

369

377

372

Total operating expenses

58,125

56,687

48,726

49,165

49,800

43,891

42,902

43,437

41,150

46,426

46,259

43,980

45,321

38,898

39,135

40,818

45,737

46,742

37,885

33,040

32,443

-54,324

16,230

32,468

35,721

16,574

14,140

11,732

12,633

15,301

13,683

16,463

16,458

14,278

11,262

8,943

7,494

6,503

7,133

Loss from operations

-125

4,243

10,759

9,895

-2,087

9,150

6,233

3,913

2,442

-2,150

-4,923

-1,924

-7,906

-654

-653

-4,789

-12,475

-14,893

-9,541

-5,458

-10,293

69,694

-1,448

-21,606

-26,578

-7,791

-5,431

-3,413

-4,565

-7,381

-5,395

-8,085

-8,317

-5,908

-3,293

-1,513

7

743

1,157

Other income

1,366

1,567

1,517

1,649

1,485

1,168

1,030

788

622

399

396

397

280

154

223

171

117

96

80

72

72

26

22

31

45

44

25

30

46

59

69

78

355

99

106

121

135

156

86

Income (loss) before income taxes

1,241

5,810

12,276

11,544

-602

10,318

7,263

4,701

3,064

-1,751

-4,527

-1,527

-7,626

-500

-430

-4,618

-12,358

-

-

-

-

-

-

-

-

-

-

-3,383

-4,519

-

-5,326

-8,007

-7,962

-5,809

-3,187

-1,392

142

899

1,243

Income Tax Expense (Benefit)

800

1,547

-88,100

18

10

-50

100

90

-2

87

23

7

19

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

-

0

0

0

-286

-113

-51

6

-2,285

-37

Net Income (Loss) Attributable to Parent

486

4,216

100,423

11,526

-612

10,360

7,171

4,611

3,066

-1,838

-4,550

-1,534

-7,645

-604

-430

-4,618

-12,358

-14,797

-9,461

-5,386

-10,221

69,720

-1,426

-21,575

-26,533

-7,747

-5,406

-3,383

-4,519

-7,322

-5,326

-8,007

-7,962

-5,523

-3,074

-1,341

136

3,184

1,280

Earnings Per Share [Abstract]
Basic (in dollars per share)

0.01

0.08

1.88

0.22

-0.01

0.20

0.14

0.09

0.07

-0.05

-0.10

-0.03

-0.17

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-0.26

-0.19

-0.28

-0.28

-0.19

-0.11

-0.05

0.00

0.11

0.05

Diluted (in dollars per share)

0.01

0.07

1.84

0.21

-0.01

0.20

0.13

0.09

0.06

-0.05

-0.10

-0.03

-0.17

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-0.26

-0.19

-0.28

-0.28

-0.19

-0.11

-0.05

0.00

0.11

0.04

Basic and diluted net loss per share

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-0.01

-0.11

-0.29

-

-0.22

-0.13

-0.24

-

-0.04

-0.64

-0.79

-

-0.17

-0.12

-0.16

-

-

-

-

-

-

-

-

-

-

Weighted average shares outstanding:
Basic (in shares)

53,806

53,398

53,297

53,101

52,752

52,541

52,389

52,172

46,336

44,938

44,885

44,718

44,398

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

28,233

28,226

28,226

28,226

28,115

28,107

28,103

28,101

28,003

27,896

Diluted (in shares)

54,870

57,513

54,541

54,579

52,752

55,300

54,709

53,945

48,225

44,938

44,885

44,718

44,398

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

28,233

28,226

28,226

28,226

27,279

28,107

28,103

28,936

28,466

28,438

Weighted average shares outstanding, basic and diluted

-

-

-

-

-

-

-

-

-

-

-

-

-

-

43,515

43,202

43,104

-

42,435

41,991

41,744

-

33,886

33,874

33,678

-

31,332

28,377

28,345

-

-

-

-

-

-

-

-

-

-